Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

Sponsor
H. Lee Moffitt Cancer Center and Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT04766164
Collaborator
(none)
4,000
1
1.1
3478.6

Study Details

Study Description

Brief Summary

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Survey

Detailed Description

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals. In addition, the study will illuminate gaps in knowledge and awareness as well as the education intervention preferences (e.g., intervention platform, source of information, timing of intervention) of individuals ages 18-45. Among those ages 27-45, shared clinical decision-making is recommended. Compared to individuals ages 18-26, individuals ages 27-45 may need to be supported uniquely so that they are prepared to engage in shared clinical decision-making about HPV vaccination with their healthcare provider. Thus, among unvaccinated individuals ages 27-45, for whom shared clinical decision-making is recommended, preparedness for engagement in shared clinical decision-making will be assessed and explored. The study also will allow investigators to identify how best to target information to young adults and mid-adults both for themselves, and among those with children, for their children.

Study Design

Study Type:
Observational
Actual Enrollment :
4000 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Health Beliefs, Behaviors, and Healthcare Experiences Among a National Sample of United States Young and Mid-Age Adults
Actual Study Start Date :
Feb 17, 2021
Actual Primary Completion Date :
Mar 24, 2021
Actual Study Completion Date :
Mar 24, 2021

Arms and Interventions

Arm Intervention/Treatment
Males and Females ages 18-26

Participants between the ages of 18-26 will complete a survey

Behavioral: Survey
Data will be obtained via self-report from participants via a one-time Qualtrics survey.

Males and Females ages 27-45

Participants between the ages of 27-45 will complete a survey

Behavioral: Survey
Data will be obtained via self-report from participants via a one-time Qualtrics survey.

Outcome Measures

Primary Outcome Measures

  1. HPV Vaccine Knowledge [Day 1]

    Data from survey will describe HPV and HPV vaccine knowledge, health beliefs, attitudes, affect, health literacy, health care experiences, vaccine discussions and information sources, preparedness for shared decision-making and HPV vaccine uptake and intentions and examine relationships between these variables among a national sample of U.S. adults (N=4,000) ages 18-45 years.

  2. HPV-Related Educational Intervention Preferences [Day 1]

    Data from survey will describe intervention preferences and associations between intervention preferences and sociodemographic variables (e.g., age, gender, race, ethnicity, socioeconomic status, employment status, parental status, and insurance status).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Age 18-45

  • Living in the United States

  • a KnowledgePanel panelist directly or via verified partners

  • Have internet access

  • Able to read, write and understand English

  • Individuals can participant regardless of their HPV vaccination status

Exclusion Criteria:
  • Individuals who do not meet inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Moffitt Cancer Center Tampa Florida United States 33612

Sponsors and Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute

Investigators

  • Principal Investigator: Shannon M Christy, PhD, Moffitt Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT04766164
Other Study ID Numbers:
  • MCC-20853
First Posted:
Feb 23, 2021
Last Update Posted:
May 31, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by H. Lee Moffitt Cancer Center and Research Institute

Study Results

No Results Posted as of May 31, 2022